Note 17 - Stock-based Compensation and Other Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2023

Notes Tables

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Twelve Months Ended December 31,
	2023			2022		2021
	(in thousands)
Stock-based compensation - equity awards	$	3,338		$	2,045	$	1,060
Stock-based compensation - liability awards		(15	)		155		1,399
Total stock-based compensation	$	3,323		$	2,200	$	2,459

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Twelve Months Ended December 31,
	2023			2022			2021
Weighted average exercise price - ($/share)	$	4.19		$	6.41		$	3.14
Expected life in years		6.4			6.0			6.0
Average expected volatility		68	%		72	%		75
Risk-free interest rate		3.73	%		1.98	%		0.95
Expected dividend yield		5.97	%		2.30	%		—
Weighted average grant date fair value - ($/share)	$	2.29		$	2.84		$	2.07

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Shares Underlying Options			Weighted Average Exercise Price Per Share			Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(in thousands)						(in years)		(in thousands)
Outstanding at January 1, 2023		444		$	3.95
Granted		335			4.19
Exercised		(168	)		(1.74	)
Unvested shares forfeited		—			—
Vested shares expired		—			—
Outstanding at December 31, 2023		611		$	4.69			8.72	$	255
Exercisable at December 31, 2023		118		$	4.56			7.60	$	116

	Number of Shares Underlying Options			Weighted Average Exercise Price Per Share			Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(in thousands)						(in years)		(in thousands)
Outstanding at January 1, 2023		387		$	1.86
Granted		—			—
Exercised		(217	)		(1.75	)
Unvested shares forfeited		—			—
Vested shares expired		—			—
Outstanding at December 31, 2023		170		$	1.99			0.27	$	425
Exercisable at December 31, 2023		170		$	1.99			0.27	$	425

Nonvested Restricted Stock Shares Activity [Table Text Block]

	Restricted Stock			Weighted Average Grant Date Fair Value
	(in thousands)
Non-vested shares outstanding at January 1, 2023		665		$	4.59
Awards granted		796			4.19
Awards vested		(354	)		3.92
Awards forfeited		(22	)		5.35
Non-vested shares outstanding at December 31, 2023		1,085		$	4.50

	Restricted Stock			Weighted Average Conversion Date Fair Value
	(in thousands)
Non-vested shares outstanding at January 1, 2023		383		$	4.27
Awards granted		183			4.19
Awards vested		(285	)		4.27
Awards forfeited		(58	)		4.23
Non-vested shares outstanding at December 31, 2023		223		$	4.22

Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]

	Restricted Stock			Weighted Average Conversion Date Fair Value
	(in thousands)
Non-vested shares outstanding at January 1, 2023		690		$	4.27
Awards granted		—			—
Awards vested		(533	)		4.27
Awards forfeited		(36	)		4.27
Non-vested shares outstanding at December 31, 2023		121		$	4.27

Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]

	Number of Shares Underlying SARs			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(in thousands)					(in years)		(in thousands)
Outstanding at January 1, 2023		202		$	1.87
Granted		—			—
Exercised		(126	)		1.59
Unvested SARs forfeited		—			—
Vested SARs expired		—			—
Outstanding at December 31, 2023		76		$	2.33		0.16	$	164
Exercisable at December 31, 2023		76		$	2.33		0.16	$	164